HMGB2 and breast carcinoma: Gao et al. [105] demonstrated that imperatorin could inhibit the invasion and migration of breast cancer cells by downregulating the expression of high mobility group box B2 (HMGB2), offering new insight into the underlying mechanism of imperatorin’s action in human breast cancer.